Investigational Drug Information for Fluoropyrimidine
✉ Email this page to a colleague
What is the development status for investigational drug Fluoropyrimidine?
Fluoropyrimidine is an investigational drug.
There have been 333 clinical trials for Fluoropyrimidine.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Eli Lilly and Company, and Hoffmann-La Roche.
There are seven hundred and fifty-one US patents protecting this investigational drug and zero international patents.
Summary for Fluoropyrimidine
| US Patents | 751 |
| International Patents | 7,266 |
| US Patent Applications | 2,432 |
| WIPO Patent Applications | 1,413 |
| Japanese Patent Applications | 768 |
| Clinical Trial Progress | Phase 3 (2019-05-05) |
| Vendors | 53 |
Recent Clinical Trials for Fluoropyrimidine
| Title | Sponsor | Phase |
|---|---|---|
| Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer | Jeeyun Lee | Phase 1/Phase 2 |
| PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer | Affiliated Hospital of North Sichuan Medical College | Phase 3 |
| PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer | Anyang Tumor Hospital | Phase 3 |
Clinical Trial Summary for Fluoropyrimidine
Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine
US Patents for Fluoropyrimidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluoropyrimidine | ⤷ Sign Up | Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) | ⤷ Sign Up |
| Fluoropyrimidine | ⤷ Sign Up | Combination therapies for cancer | MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH) | ⤷ Sign Up |
| Fluoropyrimidine | ⤷ Sign Up | Tapered looped suture | Covidien LP (Mansfield, MA) | ⤷ Sign Up |
| Fluoropyrimidine | ⤷ Sign Up | Methods of enhancing antibody-dependent cellular cytotoxicity | VentiRx Pharmaceuticals, Inc. (Seattle, WA) | ⤷ Sign Up |
| Fluoropyrimidine | ⤷ Sign Up | Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer | NuCana plc (GB) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluoropyrimidine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluoropyrimidine | World Intellectual Property Organization (WIPO) | WO2013071079 | 2031-11-09 | ⤷ Sign Up |
| Fluoropyrimidine | European Patent Office | EP3003316 | 2033-05-31 | ⤷ Sign Up |
| Fluoropyrimidine | Spain | ES2822665 | 2033-05-31 | ⤷ Sign Up |
| Fluoropyrimidine | Hong Kong | HK1223552 | 2033-05-31 | ⤷ Sign Up |
| Fluoropyrimidine | Japan | JP2016524618 | 2033-05-31 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
